Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Update: Cardiovascular Systems Posted Impressive Fiscal 2015 Q2 Earnings

Cardiovascular Systems' (CSII) fiscal 2015 second quarter revenues grew 38% year-over-year to $44.7 million. Net loss came in at $5.3 million or $0.17 per common share, compared to a net loss of $8.7 million or $0.32 per common share in the year-ago period. Coronary product revenues grew over 25% sequentially and reached $6.3 million, compared to $5 million in the fiscal 2015 first quarter.

During the quarter, the company completed one year after receiving FDA approval for its Diamondback 360 device for calcified coronary arteries in the U.S., which is a $1.5 billion market. Since the FDA approval, the company's orbital atherectomy system or OAS has been used to treat over 4,000 patients. With 18 million or more Americans suffering from peripheral arterial disease (PAD), and with over 32,000 interventional cardiologists, vascular surgeons and interventional radiologists residing in the U.S. to treat those patients, Cardiovascular's orbital atherectomy technology has huge… Read More …